SymbolBEAT
NameHEARTBEAM, INC.
SectorHEALTH CARE
RegionNorth America
IndustryMedical/Dental Instruments
Address2118 WALSH AVENUE,SUITE 210, SANTA CLARA, California, 95050, United States
Telephone+1 -408 899-4443
Fax
Email
Websitehttps://www.heartbeam.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001779372
Description

HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first ever cable-free device capable of collecting ECG signals in 3D, from 3 non-coplanar directions, and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care-all outside of a medical facility, thus redefining the future of cardiac health management.

Additional info from NASDAQ:
HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first ever cable-free device capable of collecting ECG signals in 3D, from 3 non-coplanar directions, and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care-all outside of a medical facility, thus redefining the future of cardiac health management.

2026-08-14 21:01

(99% Neutral) HEARTBEAM, INC. (BEATW) Announces Business Combination

Read more
2026-08-14 18:02

New Form 424B5 - HeartBeam, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001213900-26-090239 <b>Size:</b> 462 KB

Read more
2026-08-13 20:01

HeartBeam Reports Second Quarter 2026 Results

Read more
2026-08-03 20:15

(99% Neutral) HEARTBEAM, INC. (BEATW) Files Form 8-K

Read more
2026-07-30 11:00

HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time

Read more
2026-07-24 20:55

Persen Kenneth Harry 🟢 acquired 105.7K shares of HeartBeam, Inc. (BEAT) Transaction Date: Jul 24, 2026 | Filing ID: 081458

Read more
2026-07-24 20:54

Cruickshank Tim 🟢 acquired 167.8K shares of HeartBeam, Inc. (BEAT) Transaction Date: Jul 24, 2026 | Filing ID: 081455

Read more
2026-07-24 20:53

Director Vajdic Branislav 🟢 acquired 3.1M shares of HeartBeam, Inc. (BEAT) Transaction Date: Jun 15, 2026 | Filing ID: 081450

Read more
2026-07-15 16:19

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Read more
2026-07-15 16:19

BEAT attributes changed: Attr: Fin_status N -> D;

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT07501299 HeartBeam ECG Registry Atrial Fibrillation Recruiting 2026-03-30 2028-12-01 ClinicalTrials.gov
NCT07715474 ALIGN-ACS Pilot Study Acute Coronary Syndromes Active_Not_Recruiting 2026-03-05 2026-08-01 ClinicalTrials.gov
NCT06123130 AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection Na Arrhythmias, Cardiac Completed 2024-03-13 2024-06-20 ClinicalTrials.gov
Total clinical trials: 3
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
ECG Other Preclinical Acute Coronary Syndromes ACTIVE_NOT_RECRUITING NCT07715474
Electrocardiogram (ECG) Other Preclinical Atrial Fibrillation RECRUITING NCT07501299
Vectorcardiography (VECG) Other Approved Arrhythmias, Cardiac COMPLETED NCT06123130
Electrocardiogram (ECG) Other Preclinical Atrial Fibrillation NOT_YET_RECRUITING NCT07501299
Vectorcardiography (VECG) DEVICE Approved Arrhythmias, Cardiac COMPLETED NCT06123130
Total products: 5